0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Invasive Prenatal Testing Market Research Report 2023
Published Date: January 2023
|
Report Code: QYRE-Auto-29Y3959
Home | Market Reports | Health| Reproductive Health
Global Non Invasive Prenatal Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Non-Invasive Prenatal Testing Market Research Report 2023

Code: QYRE-Auto-29Y3959
Report
January 2023
Pages:86
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-Invasive Prenatal Testing Market Outlook -2029

The global Non-Invasive Prenatal Testing market was valued at US$ 5472.5 million in 2022 and is anticipated to reach US$ 10060 million by 2029, witnessing a CAGR of 10.7% during the forecast period 2023-2029.
 
Non Invasive Prenatal Testing Market

Non-Invasive Prenatal Testing Market Major Trends

Improvements in the reimbursement environment and increased demand for early Non-Invasive Prenatal Testing (NIPT) are two factors that are projected to propel market expansion over the forecast period. Due to the variance in contracts, noninvasive prenatal test reimbursement differs between insurance plans.

Non-Invasive Prenatal Testing Market Trends

The rise in the prevalence of chromosomal aneuploidies in fetuses, the introduction of improved non-invasive parenteral testing devices, and improvements in the reimbursement environment are the key causes of the growth in the non-invasive prenatal testing (NIPT) industry. Additionally, growing consumer awareness of non-invasive prenatal testing and unexplored market potential in Asia's emerging nations present considerable chances for revenue growth for market participants.

Due to a number of variables, including an increase in doctors preferring advanced genetic testing for high-risk pregnancies, a desire to delay childbearing, and an increase in pregnancy-related issues in the third or second trimester, NIPT is becoming more and more in demand worldwide. As a result, there is a significant need for tests that are more effective, noninvasive, and safe, and a fall in the use of these procedures. For the identification of frequently occurring trisomies in the foetus, such as Turner syndrome, Down syndrome, foetal rhesus D status, and sex chromosomal disorders, as well as for foetal sex determination, NIPT uses cell-free foetal DNA (cffDNA) that circulates in the mother's blood. This in turn is expected to drive the growth of the Non-Invasive Prenatal Testing market.

Prenatal testing is shifting towards non-invasive techniques so that the danger of miscarriage is reduced while still determining the foetal risk for genetic diseases. Novel screening techniques for foetal chromosomal aneuploidies have been developed as a result of advances in modern molecular technology and the identification of cell-free foetal DNA in maternal plasma. Chromosomal aberrations can now be found using NGS technology and cffDNA analysis thanks to its higher throughput and lower cost. Because more people are becoming aware of the benefits of non-invasive techniques, there has been a continuous increase in the development of new technology for NIPT.

Gynecologists and patients' increasing preference for using diagnostic laboratories' NIPT services reflects this end-user segment's leading position in the NIPT market as a whole in 2019. A higher volume of tests is now being outsourced to diagnostic labs due to the availability of well-equipped facilities and competent laboratory workers, which is driving a larger proportion of this market. Moreover, the expansion of the NIPT market among diagnostic labs is anticipated to be supported by the rising number of initiatives taken by diagnostic laboratories to deliver safe and reliable prenatal testing over the forecast period.

Non-Invasive Prenatal Testing Market Share Analysis

Throughout the projection period, North America is anticipated to have a dominant position in the non-invasive prenatal testing (NIPT) market. The adoption and demand for testing in this area will probably rise as a result of the region's high rates of preterm delivery, high rates of maternal death, and rising rates of chromosomal abnormalities.

Key Segmentations

By Company

  • Sequenom
  • Roche
  • Natera
  • LabCorp
  • BGI Genomics
  • Quest Diagnostics
  • Illumina
  • Berry Genomics

Segment by Type

  • High & Average Risk
  • Low Risk

Segment by Application

  • 0-12 Weeks
  • 13-24 Weeks
  • 25-36 Weeks

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Non-Invasive Prenatal Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Non-Invasive Prenatal Testing Market Report

Report Metric Details
Report Name Non-Invasive Prenatal Testing Market
The market size in 2022 USD 5472.5 Million
The revenue forecast in 2029 USD 10060 Million
Growth Rate CAGR 10.7%
Market size available for years 2022-2029
Forecast units Value (USD)
Segments covered Type, Application, Industry, Regions
Report coverage Revenue & volume forecast, company share, competitive landscape, growth factors, and trends
Geographic regions covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. What would be the forecast period in the Non-Invasive Prenatal Testing Market report?

Ans. The forecast period in the Non-Invasive Prenatal Testing Market report is from 2022 to 2029.

2. How can I get chapter-wise report/company profiles of the Global Non-Invasive Prenatal Testing industry?

Ans. The Chapter-wise Non-Invasive Prenatal Testing market report can be obtained on from the Valuates Reports website. Also, 24*7 chat support and direct call services are provided to procure the chapter-wise report.

3. What are the Segments by type in the Non-Invasive Prenatal Testing Market report?

Ans. High & Average Risk, Low Risk are the segments by type in Non-Invasive Prenatal Testing Market.

4. How big is the Non-Invasive Prenatal Testing Market?

Ans. The global Non-Invasive Prenatal Testing market was valued at US$ 5472.5 million in 2022 and is anticipated to reach US$ 10060 million by 2029, witnessing a CAGR of 10.7% during the forecast period 2023-2029.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 High & Average Risk
1.2.3 Low Risk
1.3 Market by Application
1.3.1 Global Non-Invasive Prenatal Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 0-12 Weeks
1.3.3 13-24 Weeks
1.3.4 25-36 Weeks
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Invasive Prenatal Testing Market Perspective (2018-2029)
2.2 Non-Invasive Prenatal Testing Growth Trends by Region
2.2.1 Global Non-Invasive Prenatal Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Non-Invasive Prenatal Testing Historic Market Size by Region (2018-2023)
2.2.3 Non-Invasive Prenatal Testing Forecasted Market Size by Region (2024-2029)
2.3 Non-Invasive Prenatal Testing Market Dynamics
2.3.1 Non-Invasive Prenatal Testing Industry Trends
2.3.2 Non-Invasive Prenatal Testing Market Drivers
2.3.3 Non-Invasive Prenatal Testing Market Challenges
2.3.4 Non-Invasive Prenatal Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Invasive Prenatal Testing Players by Revenue
3.1.1 Global Top Non-Invasive Prenatal Testing Players by Revenue (2018-2023)
3.1.2 Global Non-Invasive Prenatal Testing Revenue Market Share by Players (2018-2023)
3.2 Global Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Invasive Prenatal Testing Revenue
3.4 Global Non-Invasive Prenatal Testing Market Concentration Ratio
3.4.1 Global Non-Invasive Prenatal Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Prenatal Testing Revenue in 2022
3.5 Non-Invasive Prenatal Testing Key Players Head office and Area Served
3.6 Key Players Non-Invasive Prenatal Testing Product Solution and Service
3.7 Date of Enter into Non-Invasive Prenatal Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Invasive Prenatal Testing Breakdown Data by Type
4.1 Global Non-Invasive Prenatal Testing Historic Market Size by Type (2018-2023)
4.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2024-2029)
5 Non-Invasive Prenatal Testing Breakdown Data by Application
5.1 Global Non-Invasive Prenatal Testing Historic Market Size by Application (2018-2023)
5.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Non-Invasive Prenatal Testing Market Size (2018-2029)
6.2 North America Non-Invasive Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Non-Invasive Prenatal Testing Market Size by Country (2018-2023)
6.4 North America Non-Invasive Prenatal Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Invasive Prenatal Testing Market Size (2018-2029)
7.2 Europe Non-Invasive Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Non-Invasive Prenatal Testing Market Size by Country (2018-2023)
7.4 Europe Non-Invasive Prenatal Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Invasive Prenatal Testing Market Size (2018-2029)
8.2 Asia-Pacific Non-Invasive Prenatal Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Invasive Prenatal Testing Market Size (2018-2029)
9.2 Latin America Non-Invasive Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Non-Invasive Prenatal Testing Market Size by Country (2018-2023)
9.4 Latin America Non-Invasive Prenatal Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Invasive Prenatal Testing Market Size (2018-2029)
10.2 Middle East & Africa Non-Invasive Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sequenom
11.1.1 Sequenom Company Detail
11.1.2 Sequenom Business Overview
11.1.3 Sequenom Non-Invasive Prenatal Testing Introduction
11.1.4 Sequenom Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.1.5 Sequenom Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Non-Invasive Prenatal Testing Introduction
11.2.4 Roche Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Natera
11.3.1 Natera Company Detail
11.3.2 Natera Business Overview
11.3.3 Natera Non-Invasive Prenatal Testing Introduction
11.3.4 Natera Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.3.5 Natera Recent Development
11.4 LabCorp
11.4.1 LabCorp Company Detail
11.4.2 LabCorp Business Overview
11.4.3 LabCorp Non-Invasive Prenatal Testing Introduction
11.4.4 LabCorp Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.4.5 LabCorp Recent Development
11.5 BGI Genomics
11.5.1 BGI Genomics Company Detail
11.5.2 BGI Genomics Business Overview
11.5.3 BGI Genomics Non-Invasive Prenatal Testing Introduction
11.5.4 BGI Genomics Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.5.5 BGI Genomics Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Detail
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Introduction
11.6.4 Quest Diagnostics Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.6.5 Quest Diagnostics Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Non-Invasive Prenatal Testing Introduction
11.7.4 Illumina Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.7.5 Illumina Recent Development
11.8 Berry Genomics
11.8.1 Berry Genomics Company Detail
11.8.2 Berry Genomics Business Overview
11.8.3 Berry Genomics Non-Invasive Prenatal Testing Introduction
11.8.4 Berry Genomics Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.8.5 Berry Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of High & Average Risk
    Table 3. Key Players of Low Risk
    Table 4. Global Non-Invasive Prenatal Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Non-Invasive Prenatal Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Non-Invasive Prenatal Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Non-Invasive Prenatal Testing Market Share by Region (2018-2023)
    Table 8. Global Non-Invasive Prenatal Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Non-Invasive Prenatal Testing Market Share by Region (2024-2029)
    Table 10. Non-Invasive Prenatal Testing Market Trends
    Table 11. Non-Invasive Prenatal Testing Market Drivers
    Table 12. Non-Invasive Prenatal Testing Market Challenges
    Table 13. Non-Invasive Prenatal Testing Market Restraints
    Table 14. Global Non-Invasive Prenatal Testing Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Non-Invasive Prenatal Testing Market Share by Players (2018-2023)
    Table 16. Global Top Non-Invasive Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2022)
    Table 17. Ranking of Global Top Non-Invasive Prenatal Testing Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Non-Invasive Prenatal Testing Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Non-Invasive Prenatal Testing Product Solution and Service
    Table 21. Date of Enter into Non-Invasive Prenatal Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Non-Invasive Prenatal Testing Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Non-Invasive Prenatal Testing Revenue Market Share by Type (2018-2023)
    Table 25. Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Non-Invasive Prenatal Testing Revenue Market Share by Type (2024-2029)
    Table 27. Global Non-Invasive Prenatal Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Non-Invasive Prenatal Testing Revenue Market Share by Application (2018-2023)
    Table 29. Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Non-Invasive Prenatal Testing Revenue Market Share by Application (2024-2029)
    Table 31. North America Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Non-Invasive Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Non-Invasive Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Non-Invasive Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Non-Invasive Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Non-Invasive Prenatal Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Non-Invasive Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Non-Invasive Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Sequenom Company Detail
    Table 47. Sequenom Business Overview
    Table 48. Sequenom Non-Invasive Prenatal Testing Product
    Table 49. Sequenom Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 50. Sequenom Recent Development
    Table 51. Roche Company Detail
    Table 52. Roche Business Overview
    Table 53. Roche Non-Invasive Prenatal Testing Product
    Table 54. Roche Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 55. Roche Recent Development
    Table 56. Natera Company Detail
    Table 57. Natera Business Overview
    Table 58. Natera Non-Invasive Prenatal Testing Product
    Table 59. Natera Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 60. Natera Recent Development
    Table 61. LabCorp Company Detail
    Table 62. LabCorp Business Overview
    Table 63. LabCorp Non-Invasive Prenatal Testing Product
    Table 64. LabCorp Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 65. LabCorp Recent Development
    Table 66. BGI Genomics Company Detail
    Table 67. BGI Genomics Business Overview
    Table 68. BGI Genomics Non-Invasive Prenatal Testing Product
    Table 69. BGI Genomics Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 70. BGI Genomics Recent Development
    Table 71. Quest Diagnostics Company Detail
    Table 72. Quest Diagnostics Business Overview
    Table 73. Quest Diagnostics Non-Invasive Prenatal Testing Product
    Table 74. Quest Diagnostics Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 75. Quest Diagnostics Recent Development
    Table 76. Illumina Company Detail
    Table 77. Illumina Business Overview
    Table 78. Illumina Non-Invasive Prenatal Testing Product
    Table 79. Illumina Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 80. Illumina Recent Development
    Table 81. Berry Genomics Company Detail
    Table 82. Berry Genomics Business Overview
    Table 83. Berry Genomics Non-Invasive Prenatal Testing Product
    Table 84. Berry Genomics Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 85. Berry Genomics Recent Development
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-Invasive Prenatal Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Non-Invasive Prenatal Testing Market Share by Type: 2022 VS 2029
    Figure 3. High & Average Risk Features
    Figure 4. Low Risk Features
    Figure 5. Global Non-Invasive Prenatal Testing Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Non-Invasive Prenatal Testing Market Share by Application: 2022 VS 2029
    Figure 7. 0-12 Weeks Case Studies
    Figure 8. 13-24 Weeks Case Studies
    Figure 9. 25-36 Weeks Case Studies
    Figure 10. Non-Invasive Prenatal Testing Report Years Considered
    Figure 11. Global Non-Invasive Prenatal Testing Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Non-Invasive Prenatal Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Non-Invasive Prenatal Testing Market Share by Region: 2022 VS 2029
    Figure 14. Global Non-Invasive Prenatal Testing Market Share by Players in 2022
    Figure 15. Global Top Non-Invasive Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Non-Invasive Prenatal Testing Revenue in 2022
    Figure 17. North America Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Non-Invasive Prenatal Testing Market Share by Country (2018-2029)
    Figure 19. United States Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Non-Invasive Prenatal Testing Market Share by Country (2018-2029)
    Figure 23. Germany Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Non-Invasive Prenatal Testing Market Share by Region (2018-2029)
    Figure 31. China Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Non-Invasive Prenatal Testing Market Share by Country (2018-2029)
    Figure 39. Mexico Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Non-Invasive Prenatal Testing Market Share by Country (2018-2029)
    Figure 43. Turkey Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Sequenom Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 46. Roche Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 47. Natera Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 48. LabCorp Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 49. BGI Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 50. Quest Diagnostics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 51. Illumina Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 52. Berry Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS